ArticleImmunoHorizons2025
Individuals with latent tuberculosis infection display pulmonary airway enrichment and recall recruitment of CD4+ TRM with protective functional phenotypes.
Article in ImmunoHorizons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- γδ T Cells at the Crossroads of Tuberculosis and COPD: From Early Immunity to Tissue Remodeling.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Tuberculosis (TB) remains a worldwide public health threat, in part because of the limited efficacy of current BCG vaccination. Respiratory infection with Mycobacterium tuberculosis (Mtb) is most often followed by the development of protective immunity that contains the pathogen, resulting in latent tuberculosis infection (LTBI). We previously introduced bronchoscopic challenge of LTBI individuals using instillation of purified protein derivative (PPD) of Mtb to model specific induced local recall responses in the human lung. Here, we examined phenotypic and functional aspects of human airway CD4+ T cell populations in LTBI that correlate with protection from Mtb in animal infection models. Baseline bronchoalveolar lavage (BAL) was enriched for CD4+ T cells expressing the KLRG-/CD69+ tissue resident-memory (TRM) phenotype. Both Th1 (CCR6-CCR4-CXCR3+) and Th1* (CCR6+CCR4-CXCR3+) CD4+ T cell subsets demonstrated polyfunctional IFN-γ+TNF-α+ cytokine responses in response to in vitro PPD stimulation. Bronchoscopic PPD challenge, although leading to less robust cellular recruitment than observed previously, preserved the predominance of KLRG1-CD69+ TRM and also of CD4+ T cells that displayed IFN-γ+TNF-α+ dual cytokine production in response to PPD. CD4+ T cells of both control and PPD challenged human lung segments displayed increased expression of the protective CD153 molecule; CD153 expression also correlated with increased cytokine polyfunctionality, particularly of polyfunctional IFN-γ+IL-2+TNF-α+ and IFN-γ+TNF-α+ dual-positive cells. These results support the utility of BAL studies in LTBI to model human correlates of protection from Mtb with potential applicability to the design and initial evaluation of novel approaches to TB vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.